
NeuroScientific
NSB.AXNeuroScientific Biopharmaceuticals Limited Price (NSB.AX)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
144,508,886
(0.723)%
Community Sentiment
0 votes
↑ 0%
↓ 0%
Description
NeuroScientific Biopharmaceuticals Limited develops therapeutic treatments for neurodegenerative diseases through preclinical and clinical studies of patented technologies. Its lead drug candidates include EmtinB for treatment of neurodegenerative dementia and Alzheimer's disease, and degenerative conditions of the optic nerve. The company was incorporated in 2002 and is based in Cottesloe, Australia. Read More
Sector: Healthcare
- Previous Close Fetching Data...
- Range $0.033-0.078
- Market Cap 5.93M
- Enterprise Value No Data
- Avg Volume Fetching Data...
- P/E Ratio Fetching Data...
- Dividend Yield Fetching Data...
Industry: Biotechnology
- ceo: Dr. Anthony James Keating
- IPO Date: July, 27, 2018
- Country: AU
- Currency: AUD
- Headquaters: Cottesloe, WA
- Employees: No Data
- Revenue from each product or segment:
Product or Segment | Value: | % - Total | Last 3Y: |
---|

- Revenue by Region
Product or Segment | Value: | % - Total | Last 3Y: |
---|
